Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
about
Patient reported outcomes in rheumatoid arthritis clinical trialsEvaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.Reporting of patient-perceived impact of rheumatoid arthritis and axial spondyloarthritis over 10 years: a systematic literature reviewPatient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care.Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach.Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis.Development and preliminary validation of the pancreatic cancer disease impact score.The first national clinical audit for rheumatoid arthritis.Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively.Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors.Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data.Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch ModelsSarilumab: patient-reported outcomes in rheumatoid arthritis
P2860
Q26852960-B3080FE4-A93B-4019-B067-5F20F7A28BD0Q31139238-1E487FAC-57D8-49E5-9481-FD0C384C9C28Q33783951-D986DC34-400A-4BB4-A50B-F021C0C1B180Q35808064-8808A85B-AAB6-4C36-88B6-AF2247D278B5Q35977834-63556A2C-7513-4557-9890-BF1D1E94832EQ36215816-44FC170E-7ABC-4A04-B237-07587BDF05FAQ36809347-9BF8FBF6-14ED-46A7-8306-78C8A1E22BCFQ37087708-5762F80F-D386-4277-82F6-A6A010838F03Q37614715-8D4056A0-FB59-4318-9697-BD9A71E33C46Q37704288-D4E1B7B5-7F9D-4005-BC58-04BF3C278D07Q39048368-D2C8E03D-6DBE-403B-84B5-23463C4873F8Q39330884-BDBE59E0-CC3C-408A-A61E-29A1A96A21E7Q39672360-41869C32-82D4-4C62-AC4B-613E124F4E9DQ45877225-BB2BF456-0266-4D29-B30F-086BEBBD14D2Q47625199-9BF6726E-2C82-41B2-A8F6-7F93307330FDQ55360477-578F19B1-F824-4F11-84A8-8A43E42E13BFQ56331993-A2FE14D2-3464-4F3D-ABE3-A1778C139AE9Q58735831-5A0EC160-6EEC-490B-9DFE-0A9D67972985
P2860
Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@ast
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@en
type
label
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@ast
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@en
prefLabel
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@ast
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@en
P2860
P50
P356
P1476
Defining cut-off values for di ...... ritis Impact of Disease (RAID)
@en
P2093
Isabelle Logeart
Yves Brault
P2860
P2888
P356
10.1186/AR3859
P577
2012-05-30T00:00:00Z
P5875
P6179
1046315830